Sign In
Buy OSUR
$3.95
-0.0500 (-1.25%)
At Close: Jun 03, 2026
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments
04:01pm, Wednesday, 04'th Nov 2020
Net T hird Q uarter R evenues of $ 48.0 M illion Increased 33 % Year-Over-Year, D riven by $ 18 . 4 M illion in S ales of O ral F luid C ollection D evices for COVID-19 M olecular T esting
Second FDA EUA for the Subsidiary's Saliva Collection Devices Second FDA EUA for the Subsidiary's Saliva Collection Devices
OraSure's Emergency Use Authorization, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:OSUR)
11:26am, Thursday, 22'nd Oct 2020
OraSure receives emergency use authorization for OMNIgene. Keros Therapeutics initiates Phase 2 clinical trial for Myelodysplastic Syndromes.
OraSure Shares Rally On Emergency Use Authorization For COVID-19 Collection Device Test
12:00am, Monday, 19'th Oct 2020
Shares of OraSure Technologies, Inc. (NASDAQ: OSUR) were advancing strongly Monday after the diagnostic company said its DNA Genotek subsidiary's saliva...
First Hawaiian Bank Trims Stake in OraSure Technologies, Inc. (NASDAQ:OSUR)
07:08am, Friday, 09'th Oct 2020
First Hawaiian Bank lowered its stake in OraSure Technologies, Inc. (NASDAQ:OSUR) by 6.6% during the third quarter, according to the company in its most recent filing with the SEC. The institutional i
Principal Financial Group Inc. Increases Stock Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR)
08:00am, Friday, 02'nd Oct 2020
Principal Financial Group Inc. increased its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 13.6% during the second quarter, according to its most recent Form 13F filing with the Se
COVID-19 Recovery Analysis: Immunodiagnostics Market | Increasing Adoption of POCT to Boost the Market Growth | Technavio
12:00am, Wednesday, 30'th Sep 2020
The Global Immunodiagnostics Market will grow by $ 11.71 bn during 2020-2024
Man Group plc Buys 2,026 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR)
05:58am, Sunday, 27'th Sep 2020
Man Group plc raised its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 7.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Comm
OraSure Technologies (OSUR) Investor Presentation - Slideshow
02:35pm, Thursday, 10'th Sep 2020
The following slide deck was published by OraSure Technologies, Inc. in conjunction with this event..
OraSure Technologies to Present at Upcoming Investor Conferences
08:30pm, Thursday, 27'th Aug 2020
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical
Here's What OraSure Technologies, Inc.'s (NASDAQ:OSUR) Shareholder Ownership Structure Looks Like
04:39pm, Tuesday, 11'th Aug 2020
If you want to know who really controls OraSure Technologies, Inc. (NASDAQ:OSUR), then you'll have to look at the...
Is OraSure Technologies, Inc. (NASDAQ:OSUR) Popular Amongst Institutions?
04:38pm, Tuesday, 11'th Aug 2020
A look at the shareholders of OraSure Technologies, Inc. (NASDAQ:OSUR) can tell us which group is most powerful...
Global HIV Tests Market: Impact of COVID-19 for 2020 and Beyond - ResearchAndMarkets.com
12:00am, Thursday, 06'th Aug 2020
The
OraSure Technologies (OSUR) Reports Q2 Loss, Lags Revenue Estimates
11:15pm, Wednesday, 05'th Aug 2020
OraSure (OSUR) delivered earnings and revenue surprises of -77.78% and -14.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs
08:01pm, Wednesday, 05'th Aug 2020
BETHLEHEM, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and anal
